Bizengri Injection
Product Images NDC 83077-100

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bizengri (NDC 83077-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merus Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Biz01 0001 01)

BIZENGRI injection vial label displaying the product name BIZENGRI, active ingredient Zenocutuzumab, strength 20 mg/mL, and dosage form injection. The vial shows a clear glass container with a stopper and an aluminum seal. The label includes the manufacturer name, Merus US, Inc.*

FDA Label Image

Figure (Biz01 0001 02)

The image displays a clear glass vial with a gray rubber stopper and a metal seal. The vial is labeled for BIZENGRI, a Zenocutuzumab injection at 20 mg/mL strength. The product is intended for intravenous use and is manufactured by Merus US, Inc.*

FDA Label Image

Principal Display Panel – 750 mg Carton Label (Biz01 0001 03)

The packaging label for BIZENGRI® (zenocutuzumab-zbco) Injection 750 mg shows each vial contains 375 mg/18.75 mL (20 mg/mL) for intravenous infusion after dilution. The label includes storage instructions to refrigerate at 2°C to 8°C and protect from light. The labeler is Merus US, Inc., with product origin from Merus N.V., Utrecht, The Netherlands.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.